FDA warning letter
Issue date
8 Aug 2019
Issuing office
Center for Drug Evaluation and Research
Posted date
13 Aug 2019
Subject
CGMP/Active Pharmaceutical Ingredient (API)/Adulterated
Products & Services
Drugs
Lantech Pharmaceuticals
Manufacturer
Warning letter
Non-Compliance Report
Headquarters
IndiaSites
Czech RepublicIndia